Purdue University To Revolutionalise Pharmaceutical Manufacturing

Study in US: Purdue University's new academic-industry consortium is focusing on revolutionizing pharmaceutical manufacturing through advanced aseptic processing technology.

Purdue University has joined forces with Eli Lilly and Company and Merck & Co. Inc. to launch the Young Institute Pharmaceutical Manufacturing Consortium.

The consortium partners are planning to revolutionize pharmaceutical manufacturing using Purdue’s William D. and Sherry L. Young Institute for Advanced Manufacturing of Pharmaceuticals. They plan to focus on innovative aseptic manufacturing technology to ensure compliance, safety, and quality and on sterile injectables.

Karen Plaut, Purdue’s executive vice president for research said, “We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning. Through this partnership, we will have a global impact in solving complex problems in the pharmaceutical and biopharmaceutical manufacturing ecosystem.”

“Addressing pharma manufacturing challenges requires a significant advancement in technology. With an alliance of this caliber, the consortium will explore greater emphasis on both current and future advanced chemistries and accelerate research of innovative discoveries,” said Elizabeth Topp, director of the Young Institute.

Purdue University Consortium To Revolutionize Pharma Manufacturing: More Details

The consortium will develop autonomous systems, disruptive innovative technologies, digital technology, and smart AI, and enhance and elevate pharmaceutical and biopharmaceutical advanced manufacturing. The consortium will depend on the research strengths of Lilly Merck and Purdue.

Arup Roy, senior vice president, of technical services and manufacturing science at Lilly said, “Being a founding member of the Young Institute means building on the remarkable legacy of next-generation manufacturing. Together, we will transform the industry with advanced aseptic manufacturing technologies, innovative research, and top-notch education and training to bring pharmaceutical sciences into the future with sterile processing standards. Our work honors Bill Young’s visionary spirit to shape the future of manufacturing and make it a core industry competency for a lasting impact on global communities.”

Merck Senior Vice President of Manufacturing Dave Maraldo said, "Generative AI, machine learning and quantum computing are the future of the manufacturing process. If our collaborative research efforts can use smart technology to accelerate the timeline from research to market, we can reduce costs and bring critical and effective therapies to patients with greater speed. Harnessing innovation will help create a safe and sustainable future for the industry, and most importantly, allow us to better serve patients.”

Read more:

• University Of Tasmania: Applications Open For Master Of Strategic Communication
• Deakin University, VicHealth To Launch New Research Centre